Neurocrine Biosciences Inc vs Western Digital Corp — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Western Digital Corp trades at $558 (market cap $168.00B). The key difference: Western Digital Corp is far larger — about 9.7× Neurocrine Biosciences Inc's market cap, and Western Digital Corp pays a 0.12% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | WDC | |
|---|---|---|
Market Cap | $17.40B | $168.00B |
Sector | Health | Technology |
52-Week High | $180.55 | $746.23 |
52-Week Low | $123.10 | $67.06 |
Enterprise Value | $16.49B | $166.35B |
Dividend Yield | — | 0.12% |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →